Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07044271 · ClinicalTrials.gov registry record · Phase 1

A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants

A Phase 1 study of Healthy, sponsored by Eli Lilly and Company.

Recruiting
Registry status
Phase 1
Development phase
120
Enrollment target
2
Study locations

NCT07044271 is a Phase 1 study of Healthy that is actively recruiting participants, run by Eli Lilly and Company. The registered enrollment target is 120 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07044271, a Phase 1 study of Healthy, is actively recruiting participants, sponsored by Eli Lilly and Company.

RECRUITING
Registry status
Phase 1
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.

Conditions Studied

Healthy

Interventions

  • DRUG Olomorasib

Study Locations (2)

Texas

  • ICON Early Phase Services - San Antonio

Utah

  • ICON - Salt Lake City

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-07-11
Est. Completion 2025-11
Phase Phase 1

Sponsor

Eli Lilly and Company

1,341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07044271

The ClinicalTrials.gov registry entry for NCT07044271 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (81% lower). The listed sponsor is Eli Lilly and Company, which has 1,341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Olomorasib is the first listed.

NCT07044271 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Utah.

Frequently Asked Questions

What is clinical trial NCT07044271 about?

NCT07044271 is a clinical study titled "A Study of Multiple Olomorasib (LY3537982) Capsules in Healthy Participants". The main purpose of this study is to measure how much olomorasib gets into the bloodstream and how long it takes the body to get rid of it. Healthy participants will take olomorasib by mouth. The study will last about 7 weeks and will include 10 back-to-back overnight stays in the research center.

What is the current status of trial NCT07044271?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2025-07-11. Estimated completion is 2025-11.

What conditions does trial NCT07044271 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07044271?

The interventions under investigation include: Olomorasib (DRUG).

Who is sponsoring clinical trial NCT07044271?

This trial is sponsored by Eli Lilly and Company, which has 1,341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07044271 being conducted?

This trial has 2 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.